Hong Kong Entertainment Stock News

SEHK:9992
SEHK:9992Specialty Retail

Is Pop Mart International Group (SEHK:9992) Price Justified After Its Strong Multi‑Year Share Surge?

Many investors are considering whether Pop Mart International Group shares still represent good value after a strong run, or whether the price has already moved ahead of the fundamentals. The stock last closed at HK$217.2, with returns of 0.8% over 7 days, an 11.1% decline over 30 days, 12.5% year to date and 71.9% over 1 year, along with a very large 3-year return. Recent attention has focused on how Pop Mart fits into consumer trends in collectibles and branded merchandise, with investors...
SEHK:2228
SEHK:2228Life Sciences

Assessing XtalPi Holdings (SEHK:2228) Valuation After New CFO With Global Healthcare Capital Markets Experience

New CFO appointment puts financial leadership in focus XtalPi Holdings (SEHK:2228) has appointed Mr. Zhou Feiran as chief financial officer, effective 10 March 2026. The move is drawing investor attention to the company’s capital markets expertise and future funding and transaction decisions. See our latest analysis for XtalPi Holdings. At a share price of HK$9.09, XtalPi Holdings has seen a 1-day share price return of 1.91% but a 30-day share price return decline of 19.20%. The 1-year total...
SEHK:1211
SEHK:1211Auto

Is It Time To Reconsider BYD (SEHK:1211) After Mixed Returns And EV Sector Shifts

If you are wondering whether BYD's current share price still offers value, the recent moves and mixed return profile make it a stock worth looking at more closely. The share price last closed at HK$107.0, with returns of 2.4% over 7 days, 12.1% over 30 days, 8.4% year to date, but a 16.6% decline over 1 year, set against gains of 56.6% over 3 years and 94.6% over 5 years. These returns sit against an ongoing flow of news around electric vehicles, policy shifts, and competition in the auto...
SEHK:1316
SEHK:1316Auto Components

Evaluating Nexteer Automotive Group’s Valuation After Its Latest 2025 Earnings Report

Earnings context for Nexteer Automotive Group (SEHK:1316) Nexteer Automotive Group (SEHK:1316) has just released full year 2025 results, with sales of US$4,584.22 million and net income of US$102 million, drawing fresh attention to the stock. Basic and diluted earnings per share from continuing operations were US$0.041, compared with US$0.025 a year earlier, giving investors updated insight into the company’s recent profitability profile. See our latest analysis for Nexteer Automotive...
SEHK:816
SEHK:816Real Estate

Jinmao Property Services (SEHK:816) Margin Decline Challenges Bullish Earnings Growth Narratives

Jinmao Property Services (SEHK:816) has released its FY 2025 results with first half revenue of C¥1.8b and basic EPS of C¥0.20, setting the tone for how the full year is shaping up. The company has seen revenue move from C¥1.49b in 1H 2024 to C¥1.47b in 2H 2024 and then to C¥1.78b in 1H 2025, while basic EPS has ranged from C¥0.19 in 1H 2024 to C¥0.22 in 2H 2024 and C¥0.20 in 1H 2025. This gives investors a clearer view of how the top line and EPS are tracking across recent periods. With...
SEHK:291
SEHK:291Beverage

China Resources Beer (SEHK:291) One Off CN¥2.4b Loss Tests Bullish Earnings Narratives

China Resources Beer (Holdings) (SEHK:291) reported mixed FY 2025 results, with second half revenue of C¥14.0b and a basic EPS loss of C¥0.75, set against trailing 12 month revenue of C¥38.0b and EPS of C¥1.04. The company has seen half year revenue move from C¥14.9b in 2H 2024 to C¥23.9b in 1H 2025 and then C¥14.0b in 2H 2025, while basic EPS shifted from C¥0.01 in 2H 2024 to C¥1.78 in 1H 2025 before the recent loss. This sets up a story where investors are weighing compressed margins and a...
SEHK:2136
SEHK:2136Multiline Retail

Lifestyle China Group (SEHK:2136) EPS Loss Persists And Reinforces Bearish Narratives

Fresh from its FY 2025 update, Lifestyle China Group (SEHK:2136) posted first half revenue of C¥617.8 million with a basic EPS loss of C¥0.002547, setting a cautious tone around profitability. The company has seen half yearly revenue move from C¥644.6 million and EPS of C¥0.028453 in 1H 2024 to C¥608.0 million and an EPS loss of C¥0.042181 in 2H 2024. Trailing 12 month figures show C¥1.21 billion of revenue and an EPS loss of C¥0.021, which keeps the focus firmly on earnings pressure. For you...
SEHK:1426
SEHK:1426Office REITs

Spring REIT (SEHK:1426) Revenue Slide Reinforces Bearish Income Narratives

Spring Real Estate Investment Trust (SEHK:1426) has just posted its FY 2025 numbers, with first half revenue of C¥322.6 million and basic EPS of C¥0.024. This sets the tone for a year where income generation and payout capacity are firmly in focus for unitholders. Over the recent periods, revenue has moved from C¥361.5 million in 1H 2024 to C¥341.0 million in 2H 2024 and C¥322.6 million in 1H 2025. Basic EPS shifted from C¥0.029 in 1H 2024 to C¥0.061 in 2H 2024 and C¥0.024 in 1H 2025, giving...
SEHK:662
SEHK:662Insurance

Asia Financial Holdings (SEHK:662) Margin Expansion Challenges Low P/E Value Narrative

Asia Financial Holdings (SEHK:662) has just posted its FY 2025 first half numbers, with revenue of HK$1,772.6 million, basic EPS of HK$0.46 and trailing 12 month EPS of HK$1.14 anchoring the latest set of results. The company has seen revenue move from HK$1,915.6 million in 1H FY 2024 to HK$1,848.8 million in 2H FY 2024 and HK$1,772.6 million in 1H FY 2025. Basic EPS tracked from HK$0.39 to HK$0.31 and now HK$0.46, setting the context for the reported 62.7% year over year earnings growth and...
SEHK:683
SEHK:683Real Estate

Kerry Properties (SEHK:683) EPS Rebound To HK$0.42 Tests Bearish Profitability Narratives

Kerry Properties (SEHK:683) has released its FY 2025 figures with first half revenue at HK$8.1b and basic EPS of HK$0.42, setting the tone for how the rest of the year might look. Over the last three reported halves, revenue has moved from HK$5.0b in 1H 2024 to HK$14.5b in 2H 2024 and then to HK$8.1b in 1H 2025. Over the same periods, basic EPS has shifted from HK$0.54 to HK$0.01 and then to HK$0.42, giving investors a clearer view of how the topline and EPS pattern is evolving through the...
SEHK:3918
SEHK:3918Hospitality

NagaCorp (SEHK:3918) Net Margin Surge Tests Single Market Risk Narratives

NagaCorp (SEHK:3918) has put up a solid set of FY 2025 numbers, with first half revenue of US$320.6 million and basic EPS of US$0.0336, set against reported earnings growth of 182.8% year over year and a five year compound growth rate of 45.7% per year. The company has seen revenue move from US$252.9 million in the second half of 2024 to US$320.6 million in the first half of 2025, while basic EPS shifted from US$0.0250 to US$0.0336 over the same periods. Investors will be weighing these...
SEHK:6181
SEHK:6181Luxury

Laopu Gold (SEHK:6181) EPS Surge To C¥13.38 Tests Bullish Growth Narratives

Laopu Gold (SEHK:6181) has released its FY 2025 numbers with first half revenue of C¥12.4b and basic EPS of C¥13.38, set against trailing twelve month revenue of C¥27.3b and EPS of C¥28.35 that reflect earnings growth of 230.5% over the past year and an average of 66.3% per year over five years. Over recent periods the company has seen revenue move from C¥3.5b in 1H 2024 to C¥5.0b in 2H 2024 and then to C¥12.4b in 1H 2025, while basic EPS has shifted from C¥4.11 to C¥5.27 and then to C¥13.38,...
SEHK:81
SEHK:81Real Estate

China Overseas Grand Oceans Group (SEHK:81) Tight 0.8% Margin Reinforces Bearish Profitability Narratives

China Overseas Grand Oceans Group (SEHK:81) has put fresh numbers on the table for FY 2025, with first half revenue at C¥14.5b and basic EPS of C¥0.08. The trailing 12 month view shows revenue of C¥36.9b and EPS of C¥0.09 as the broader backdrop. Over the past three reported halves, revenue has moved from C¥21.9b in 1H 2024 to C¥24.0b in 2H 2024 and then to C¥14.5b in 1H 2025, with basic EPS shifting from C¥0.25 to C¥0.02 and then C¥0.08. This sets up a mixed picture that investors will weigh...
SEHK:1061
SEHK:1061Biotechs

Essex Bio Technology SEHK 1061 Margin Drift Tests Bullish Undervaluation Narrative

Essex Bio-Technology (SEHK:1061) has opened FY 2025 with first half revenue of HK$876.5 million and basic EPS of HK$0.29, setting the tone for how investors will read the latest set of numbers. The company has seen revenue move from HK$828.5 million in 1H 2024 to HK$858.2 million in 2H 2024 and then HK$876.5 million in 1H 2025, while basic EPS shifted from HK$0.28 to HK$0.26 and then HK$0.29 over the same periods. This gives a clear view of how the top and bottom lines are tracking into the...
SEHK:2268
SEHK:2268Life Sciences

WuXi XDC Cayman (SEHK:2268) Margin Slip Tests Bullish Growth Narrative After FY 2025 Earnings

WuXi XDC Cayman (SEHK:2268) has posted FY 2025 results that put the focus squarely on scale, with second half revenue of C¥3.2b and basic EPS of C¥0.60, underpinned by trailing twelve month revenue of C¥5.9b and EPS of C¥1.22. The company has seen revenue move from C¥2.4b in the second half of 2024 to C¥3.2b in the second half of 2025, with basic EPS over that period shifting from C¥0.48 to C¥0.60 as investors weigh a trailing net margin of 24.9% against a slightly lower level a year ago. See...
SEHK:386
SEHK:386Oil and Gas

Is It Time To Reassess Sinopec (SEHK:386) After The Recent Share Price Pullback?

Wondering whether China Petroleum & Chemical at HK$4.53 still offers value, or if the easy gains are behind it? This article walks through what the current price really reflects. The stock has seen a 5.0% decline over the last 7 days and a 16.3% decline over the last 30 days, yet it shows returns of 15.5% over 1 year, 23.5% over 3 years and 67.3% over 5 years. Recent market conversations around China Petroleum & Chemical have focused on how its share price performance lines up with broader...
SEHK:6990
SEHK:6990Biotechs

Is It Time To Reassess Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) After Recent Share Price Weakness?

Wondering whether Sichuan Kelun-Biotech Biopharmaceutical is still priced attractively, or if the easy value has already been taken? This breakdown focuses squarely on what you are paying versus what you are getting. The share price recently closed at HK$397.60, after a 4.4% decline over the last week and a 4.6% decline over the past month, while the 1 year return sits at 52.6%. Recent news coverage has focused on Sichuan Kelun-Biotech Biopharmaceutical in the context of investor interest in...